Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ 42 induced cytotoxicity

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Da Costa Dias, Bianca ^a   Jovanovic, Katarina ^a   Gonsalves, Danielle ^a   Moodley, Kiashanee ^a   Reusch, Uwe ^b   Knackmuss, Stefan ^b   Penny, Clement ^a   Weinberg, Marc S ^a   Little, Melvyn ^b   Weiss, Stefan F T ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Affimed GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; LAMININ RECEPTOR; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA;

ARTICLE; CELL LINE; CELL MEMBRANE; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT;

AMYLOID BETA-PEPTIDES; ANTIBODIES, MONOCLONAL; CELL LINE; CELL MEMBRANE; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, LAMININ; RNA, SMALL INTERFERING;

EID: 84884646966     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02702     Document Type: Article

References (37)

1. Verdier, Y. & Penke, B. Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. Curr Protein Pept Sci 5, 19-31 (2004) (Pubitemid 38279402)
2. Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189, doi:10.1101/cshperspect.a006189 (2011)
3. Gonsalves, D., Jovanovic, K., Da Costa Dias, B. & Weiss, S. F. Global Alzheimer Research Summit: basic and clinical research: present and future Alzheimer research. Prion 6, 7-10, doi:10.4161/pri.6.1.18854 (2012)
4. Kakiya, N. et al. Cell surface expression of the major amyloid-beta peptide (Abeta)-degrading enzyme, neprilysin, depends on phosphorylation by mitogenactivated protein kinase/extracellular signal-regulated kinase kinase (MEK) and dephosphorylation by protein phosphatase 1a. J Biol Chem 287, 29362-29372, doi:10.1074/jbc.M112.340372 (2012)
5. Jarrett, J. T., Berger, E. P. & Lansbury, P. T., Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697 (1993) (Pubitemid 23162022)
6. Saido, T. C. Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid. Neurobiol Aging 19, S69-75 (1998) (Pubitemid 28178942)
7. Spires-Jones, T. L. et al. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am J Pathol 171, 1304-1311, doi:10.2353/ajpath.2007.070055 (2007) (Pubitemid 47582903)
8. Koffie, R. M. et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 106, 4012-4017, doi:10.1073/pnas.0811698106 (2009)
9. Hyman, B. T. et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome) Proc Natl Acad Sci U S A 92, 3586-3590 (1995)
10. Mucke, L. & Selkoe, D. J. Neurotoxicity of Amyloid beta-Protein: Synaptic and Network Dysfunction. Cold Spring Harb Perspect Med 2, a006338, doi:10.1101/cshperspect.a006338 (2012)
11. Stefani, M. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J 277, 4602-4613, doi:10.1111/j.1742-4658.2010.07889.x (2010)
12. Sepulveda, F. J., Parodi, J., Peoples, R. W., Opazo, C. & Aguayo, L. G. Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820, doi:10.1371/journal.pone.0011820 (2010)
13. Demuro, A. et al. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300, doi:10.1074/jbc.M500997200 (2005) (Pubitemid 41389198)
14. Lin, H., Bhatia, R. & Lal, R. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J 15, 2433-2444, doi:10.1096/fj.01-0377com (2001) (Pubitemid 33063171)
15. Marchesi, V. T. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25, 5-13, doi:10.1096/fj.11-0102ufm (2011)
16. Bartzokis, G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging 32, 1341-1371, doi:10.1016/j.neurobiolaging. 2009.08.007 (2011)
17. Da Costa Dias, B., Jovanovic, K., Gonsalves, D. & Weiss, S. F. Structural and mechanistic commonalities of amyloid-beta and the prion protein. Prion 5, 126-137, doi:10.4161/pri.5.3.17025 (2011)
18. Li, S. et al. Soluble oligomers of amyloid Beta protein facilitate hippocampal longterm depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801, doi:10.1016/j.neuron.2009.05.012 (2009)
19. Kudo, W. et al. Cellular prion protein is essential for oligomeric amyloid-betainduced neuronal cell death. Hum Mol Genet 21, 1138-1144, doi:10.1093/hmg/ddr542 (2012)
20. Resenberger, U. K. et al. The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J 30, 2057-2070, doi:10.1038/emboj.2011.86 (2011)
21. Parkin, E. T. et al. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A 104, 11062-11067, doi:10.1073/pnas.0609621104 (2007) (Pubitemid 47175226)
22. Leucht, C. et al. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep 4, 290295-, doi:10.1038/sj.embor.embor768 (2003) (Pubitemid 36511726)
23. Mbazima, V., Da Costa Dias, B., Omar, A., Jovanovic, K. & Weiss, S. F. Interactions between PrP(c) and other ligands with the 37-kDa/67-kDa laminin receptor. Front Biosci 15, 1150-1163 (2010)
24. Omar, A. et al. Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor. Expert Opin Ther Pat 21, 35-53, doi:10.1517/13543776.2011.539203 (2011)
25. Gauczynski, S. et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20, 5863-5875, doi:10.1093/emboj/20.21.5863 (2001) (Pubitemid 33049262)
26. Hundt, C. et al. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J 20, 5876-5886, doi:10.1093/emboj/20.21.5876 (2001) (Pubitemid 33049263)
27. Gauczynski, S. et al. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J Infect Dis 194, 702-709, doi:10.1086/505914 (2006) (Pubitemid 44297858)
28. Zuber, C. et al. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. J Mol Biol 378, 530-539, doi:10.1016/j.jmb.2008.02.004 (2008)
29. Omar, A., Reusch, U., Knackmuss, S., Little, M. & Weiss, S. F. Anti-LRP/LRspecific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells. J Mol Biol 419, 102-109, doi:10.1016/j.jmb.2012.02.035 (2012)
30. Khumalo, T. et al. Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18. PLoS One 8, e66297, doi:10.1371/journal.pone.0066297 (2013)
31. Khusal, R. et al. In vitro inhibition of angiogenesis by antibodies directed against the 37 kDa/67 kDa laminin receptor. PLoS One 8, e58888, doi:10.1371/journal.pone.0058888 (2013)
32. Kibbey, M. C. et al. beta-Amyloid precursor protein binds to the neuritepromoting IKVAV site of laminin. Proc Natl Acad Sci U S A 90, 10150-10153 (1993) (Pubitemid 23328269)
33. Lacor, P. N. et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24, 10191-10200, doi:10.1523/JNEUROSCI.3432-04.2004 (2004) (Pubitemid 39492046)
34. Manczak,M., Calkins, M. J.&Reddy, P. H. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 20, 2495-2509, doi:10.1093/hmg/ddr139 (2011)
35. Venticinque, L., Jamieson, K. V. & Meruelo, D. Interactions between laminin receptor and the cytoskeleton during translation and cell motility. PLoS One 6, e15895, doi:10.1371/journal.pone.0015895 (2011)
36. Givant-Horwitz, V.,Davidson, B.&Reich, R. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res 64, 3572-3579, doi:10.1158/0008-5472.CAN-03-3424 (2004) (Pubitemid 38657934)
37. Jovanovic, J. et al. Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease. Sci. Rep. 3, 2699; doi:10.1038/srep02699 (2013).